SKI Market

A+| A| A-|

Indian Indices

Sensex

77,877.77 -638.72
( -0.81%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,542.04 192.87
(0.32%)

Nikkei 225

10,480.54 -17.55
(-0.17%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

21.89

101577.75

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.66

Date	Headline
06-Mar-2026	Dr Reddy's Lab gets EIR from USFDA for Srikakulam facility
19-Feb-2026	Dr. Reddy’s Labs acquires 'Progynova' portfolio from UK's Mercury Pharma Group
19-Feb-2026	Nifty drops below 25,650 mark; auto shares snap 2-day gains
22-Jan-2026	Dr Reddy’s Lab Q3 PAT drops 14% YoY to Rs 1,210 cr
21-Jan-2026	Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter
01-Jan-2026	Dr Reddy’s Swiss subsidiary gets USFDA CRL for biosimilar AVT03
24-Dec-2025	Dr Reddys Laboratories to announce Quarterly Result
09-Dec-2025	Dr Reddys Laboratories allots 9,165 equity shares under ESOS
08-Dec-2025	Dr Reddy’s Lab arm inks pact with Immutep SAS for novel cancer immunotherapy
01-Dec-2025	Dr Reddys Laboratories Ltd up for five straight sessions

<< < 1 2 3 > >>

77,877.77 -638.72 ( -0.81%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,542.04 192.87 (0.32%)

10,480.54 -17.55 (-0.17%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)